Lundbeck moves Lu AA39959 into clinical phase II for the treatment of … - Phramalive.com
COPENHAGEN, Dec. 19, 2008-H. Lundbeck A/S strengthens its pipeline of pharmaceuticals in clinical development by initiating clinical phase II trials with Lu AA39959. The decision is based on positive pre-clinical results as well as positive …